• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆抗体制剂中唾液酸O-乙酰酯酶对聚山梨酯20的降解作用

Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations.

作者信息

Zhang Sisi, Xiao Hui, Li Ning

机构信息

Analytical Chemistry, Regeneron Pharmaceuticals, Tarrytown, NY, United States.

Analytical Chemistry, Regeneron Pharmaceuticals, Tarrytown, NY, United States.

出版信息

J Pharm Sci. 2021 Dec;110(12):3866-3873. doi: 10.1016/j.xphs.2021.09.001. Epub 2021 Sep 4.

DOI:10.1016/j.xphs.2021.09.001
PMID:34487744
Abstract

Polysorbates (PS) are surfactants commonly added in biologics formulations that can protect proteins from denaturation and aggregation. However, decreases in polysorbate 20 (PS20) content have been observed in some monoclonal antibody formulations, causing the formation of visible and/or subvisible particles that ultimately compromise the quality and stability of the therapeutic protein products. It was determined that the particles are mainly composed of free fatty acid, suggesting enzymatic hydrolysis of PS is responsible for the degradation of PS. Enrichment of host cell proteins (HCPs) by immunoprecipitation followed by shotgun proteomics have been utilized to identify the HCPs that can hydrolyze PS20. One HCP, sialate O-acetylesterase (SIAE), demonstrated strong enzymatic activity for PS20 degradation even at low concentration (<5 ppm level). Incubation of recombinant SIAE with PS20 resulted in a unique degradation pattern where the hydrolysis of monoester with short fatty acid chain (C12, C14) was observed but not the monoester with long fatty acid chain (C16, C18) or higher-order esters. SIAE was detected and quantitated in several formulated mAbs, and the amount of SIAE was positively correlated to PS20 degradation in these mAbs during incubation. Additional experiments also showed that when SIAE was depleted, PS20 degradation was diminished, suggesting a causality between SIAE and PS20 degradation. The lipase activity of SIAE is specific to PS20, but not to PS 80 (PS80), which contains monoesters with long chain fatty acid (C18) and higher-order esters. The specific esterase activity of SIAE on PS20 suggests a possible solution of using PS80 over PS20 to eliminate surfactant degradation in mAb products.

摘要

聚山梨酯(PS)是生物制剂配方中常用的表面活性剂,可保护蛋白质免于变性和聚集。然而,在一些单克隆抗体制剂中观察到聚山梨酯20(PS20)含量下降,导致形成可见和/或亚可见颗粒,最终影响治疗性蛋白质产品的质量和稳定性。已确定这些颗粒主要由游离脂肪酸组成,这表明PS的酶促水解是PS降解的原因。通过免疫沉淀富集宿主细胞蛋白(HCP),然后进行鸟枪法蛋白质组学分析,以鉴定能够水解PS20的HCP。一种HCP,唾液酸O-乙酰酯酶(SIAE),即使在低浓度(<5 ppm水平)下也表现出对PS20降解的强酶活性。重组SIAE与PS20孵育产生了独特的降解模式,其中观察到短脂肪酸链(C12、C14)单酯的水解,但长脂肪酸链(C16、C18)单酯或高阶酯未被水解。在几种配制的单克隆抗体中检测并定量了SIAE,并且在孵育期间这些单克隆抗体中SIAE的量与PS20降解呈正相关。额外的实验还表明,当SIAE被去除时,PS20降解减少,这表明SIAE与PS20降解之间存在因果关系。SIAE的脂肪酶活性对PS20具有特异性,但对PS 80(PS80)不具有特异性,PS80含有长链脂肪酸(C18)单酯和高阶酯。SIAE对PS20的特异性酯酶活性表明,在单克隆抗体产品中使用PS80而非PS20可能是消除表面活性剂降解的一种解决方案。

相似文献

1
Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations.单克隆抗体制剂中唾液酸O-乙酰酯酶对聚山梨酯20的降解作用
J Pharm Sci. 2021 Dec;110(12):3866-3873. doi: 10.1016/j.xphs.2021.09.001. Epub 2021 Sep 4.
2
Improving Prediction of Free Fatty Acid Particle Formation in Biopharmaceutical Drug Products: Incorporating Ester Distribution during Polysorbate 20 Degradation.提高生物制药制剂中游离脂肪酸粒子形成预测的准确性:在聚山梨酯 20 降解过程中考虑酯分布。
Mol Pharm. 2020 Nov 2;17(11):4354-4363. doi: 10.1021/acs.molpharmaceut.0c00794. Epub 2020 Oct 8.
3
Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations.聚山梨酯 20 的酶降解模式影响单克隆抗体制剂的界面性质。
Eur J Pharm Biopharm. 2024 Jan;194:74-84. doi: 10.1016/j.ejpb.2023.11.024. Epub 2023 Nov 30.
4
Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases.鉴定含有多种脂肪酶的单克隆抗体制剂中聚山梨酯 20 降解的具体原因。
Pharm Res. 2022 Jan;39(1):75-87. doi: 10.1007/s11095-021-03160-3. Epub 2022 Jan 3.
5
Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins.应激介导的聚山梨酯 20 降解及其对治疗性蛋白的潜在影响。
Pharm Res. 2024 Jun;41(6):1217-1232. doi: 10.1007/s11095-024-03700-7. Epub 2024 May 13.
6
Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations.单克隆抗体制剂中十五族溶酶体磷脂酶A2异构体X1对聚山梨酯20和80的降解作用
J Pharm Sci. 2016 May;105(5):1633-1642. doi: 10.1016/j.xphs.2016.02.022. Epub 2016 Apr 5.
7
Comparison of Protein Particle Formation in IgG1 mAbs Formulated with PS20 Vs. PS80 When Subjected to Interfacial Dilatational Stress.在受到界面扩张压力时,用 PS20 和 PS80 配制的 IgG1 mAbs 中蛋白颗粒形成的比较。
AAPS PharmSciTech. 2023 Apr 20;24(5):104. doi: 10.1208/s12249-023-02561-4.
8
A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation.全油酸聚山梨酯 80 的综合评估:游离脂肪酸粒子形成、界面保护和氧化降解。
Pharm Res. 2021 Mar;38(3):531-548. doi: 10.1007/s11095-021-03021-z. Epub 2021 Mar 12.
9
Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.聚山梨酯酯级分的特性及其对蛋白药物产品稳定性的影响。
Mol Pharm. 2020 Jul 6;17(7):2345-2353. doi: 10.1021/acs.molpharmaceut.0c00093. Epub 2020 Jun 5.
10
How enzymatic hydrolysis of polysorbate 20 influences colloidal protein stability.聚山梨酯 20 的酶解如何影响胶体蛋白稳定性。
Eur J Pharm Sci. 2023 Dec 1;191:106597. doi: 10.1016/j.ejps.2023.106597. Epub 2023 Sep 26.

引用本文的文献

1
Polysorbates degrading enzymes in biotherapeutics - a current status and future perspectives.生物治疗药物中的聚山梨酯降解酶——现状与未来展望
Front Bioeng Biotechnol. 2025 Jan 10;12:1490276. doi: 10.3389/fbioe.2024.1490276. eCollection 2024.
2
Proteomics Reveals Distinctive Host Cell Protein Expression Patterns in Fed-Batch and Perfusion Cell Culture Processes.蛋白质组学揭示了补料分批培养和灌注细胞培养过程中宿主细胞独特的蛋白质表达模式。
Biotechnol J. 2025 Jan;20(1):e202400567. doi: 10.1002/biot.202400567.
3
Comparative Stability Study of Polysorbate 20 and Polysorbate 80 Related to Oxidative Degradation.
聚山梨醇酯20和聚山梨醇酯80与氧化降解相关的稳定性比较研究
Pharmaceutics. 2023 Sep 16;15(9):2332. doi: 10.3390/pharmaceutics15092332.
4
Oxidation of polysorbates - An underestimated degradation pathway?聚山梨酯的氧化——一种被低估的降解途径?
Int J Pharm X. 2023 Jul 27;6:100202. doi: 10.1016/j.ijpx.2023.100202. eCollection 2023 Dec 15.
5
Prediction of long-term polysorbate degradation according to short-term degradation kinetics.根据短期降解动力学预测聚山梨酯的长期降解情况。
MAbs. 2023 Jan-Dec;15(1):2232486. doi: 10.1080/19420862.2023.2232486.
6
Low-Abundance Protein Enrichment for Medical Applications: The Involvement of Combinatorial Peptide Library Technique.低丰度蛋白质在医学中的应用:组合肽文库技术的参与。
Int J Mol Sci. 2023 Jun 19;24(12):10329. doi: 10.3390/ijms241210329.
7
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates.蛋白质治疗药物中用于蛋白质稳定化的替代辅料:克服聚山梨酯的局限性
Pharmaceutics. 2022 Nov 23;14(12):2575. doi: 10.3390/pharmaceutics14122575.
8
Analysis of Host Cell Proteins in Monoclonal Antibody Therapeutics Through Size Exclusion Chromatography.通过凝胶排阻色谱法分析单克隆抗体治疗药物中的宿主细胞蛋白。
Pharm Res. 2022 Nov;39(11):3029-3037. doi: 10.1007/s11095-022-03381-0. Epub 2022 Sep 7.
9
Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro.贝伐珠单抗(Beovu)会损害体外培养的视网膜内皮细胞形成的屏障功能,但雷珠单抗(Lucentis)不会。
Sci Rep. 2022 Jul 21;12(1):12493. doi: 10.1038/s41598-022-16770-7.
10
Characterization of radicals in polysorbate 80 using electron paramagnetic resonance (EPR) spectroscopy and spin trapping.利用电子顺磁共振(EPR)光谱和自旋捕获技术对聚山梨酯80中的自由基进行表征。
Int J Pharm X. 2022 Jun 23;4:100123. doi: 10.1016/j.ijpx.2022.100123. eCollection 2022 Dec.